| 000 | 03119nam a2200445 c 4500 | ||
|---|---|---|---|
| 710 | 2 |
_aSpringerLink (Online service) _9106996 |
|
| 999 |
_c117875 _d117875 _x1 |
||
| 001 | 117875 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102113831.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 191031s2019 si a o |||| 0|eng d | ||
| 020 | _a9789811381775 | ||
| 024 | 7 |
_a10.1007/978-981-13-8177-5 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQH447 _b2019 EB |
|
| 245 | 0 | 0 |
_aGenome-Wide Association Studies _cedited by Tatsuhiko Tsunoda, Toshihiro Tanaka, Yusuke Nakamura. |
| 250 | _aFirst edition | ||
| 264 | 1 |
_aSingapore _bSpringer International Publishing _c2019 |
|
| 300 |
_a1 recurso en línea (IX, 209 páginas) _b9 ilustraciones, 7 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 | _aBiomedical and Life Sciences (Springer-11642) | |
| 505 | 0 | _aGenotyping and Statistical Analysis -- Genetics of coronary artery disease -- Genetic and Functional Genetics of Autoimmune Diseases -- Genome-Wide Association Study for Type 2 diabetes -- The association of single nucleotide polymorphisms with cancer risk -- Genetics of Infectious Diseases -- Pharmacogenomics -- The Future of and Beyond GWAS. | |
| 520 | 3 | _aThis book examines the utility of genome-wide association studies (GWAS) in the era of next-generation sequencing and big data, identifies limitations and potential means of overcoming them, and looks to the future of GWAS and what may lay beyond. GWAS are among the most powerful tools for elucidating the genetic aspects of human and disease diversity. In Genome-Wide Association Studies, experts in the field explore in depth the impacts of GWAS on genomic research into a variety of common diseases, including cardiovascular, autoimmune, diabetic, cancer, and infectious diseases. The book will equip readers with a sound understanding both of the types of disease and phenotypes that are suited for GWAS and of the ways in which a road map resulting from GWAS can lead to the realization of personalized/precision medicine: functional analysis, drug seeds, pathway analysis, disease mechanism, risk prediction, and diagnosis. | |
| 988 | _aPrimersemestre_2020_BiomedLife | ||
| 650 | 7 |
_2embne _aGenómica _9164326 |
|
| 700 | 1 |
_aTsunoda, Tatsuhiko _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aTanaka, Toshihiro _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aNakamura, Yusuke _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _994143 |
|
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811381768 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811381782 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811381799 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-8177-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE _n0 |
||
| 998 |
_b03/2020 _dz _ek _zSI |
||